Lupin Launches Generic Safyral Tablets In The Us
Mylan, Biocon Receive MAA
You May Interested In
2026-07-22
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
This Week TDI Market Focus Shifts Downward (8.11-8.15) in China
-
Eli Lilly Strikes $1.3 Billion AI Deal with Superluminal for Next-Gen Obesity Drugs Targets GPCR Breakthrough
-
Dow and Celanese Retreat: European and Korean Cutbacks as China Expands
-
Univar Solutions and BASF Expand Distribution Agreement
-
Eastman and Huafon Chemical to Establish Cellulose Acetate Yarn Production Plant in China
-
L'Oréal to Invest $80 Million in Mexico Factory Expansion
-
A Rare Vote of Confidence: INEOS to Invest €250 Million in French Cracker Plant
-
Sinopec Engineering Group Reports 10% Revenue Growth in H1 2025, with Overseas Business Surging 92%
-
Toray to Transfer Stake in Soda Aromatic to Samyang
-
October Phosphate Market Trends: Initially Down, Then Up
Recommend Reading
-
ExxonMobil Shuts Another Singapore Facility: The Global Petrochemical Shake-Up Leaves No Easy Winners
-
Lilly’s Indiana Investment Puts API Capacity at the Center of Obesity Drug Competition
-
Syngenta’s VIRESTINA Targets Resistant Weeds as Herbicide Innovation Regains Urgency
-
BASF’s Price Increase Shows Pharma Excipients Are Still Exposed to Chemical Cost Pressure
-
Brazil’s Pesticide Registration Momentum Keeps Latin America at the Center of Agrochemical Competition
-
On March 18, the Chinese epichlorohydrin market continued to decline
-
Early September Acetic Acid Market Remains Strong
-
Chinese Hydrofluoric Acid Market Shows a Steady and Slightly Strong Trend
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
Limited Positive Factors Drive Downward Trend in Shandong Butanol Prices in Early September